Related to the project

The Impact of Choice of NNRTI on Short-Term Treatment Outcomes among HIV-Infected Patients Prescribed Tenofovir and Lamivudine in Johannesburg, South Africa

Kate Shearer, Matthew P. Fox, Mhairi Maskew, Rebecca Berhanu, Lawrence Long, Ian Sanne

PLOS ONE. 2013 Aug; 8(8).

Effect of home based HIV counselling and testing intervention in rural South Africa: cluster randomised trial

Doherty T, Tabana H, Naik R, Zembe W, Jackson D, Lombard C, Swanevelder S, Fox MP, Thorson A, Ekström AM, Chopra M

BMJ. 2013 Jun; 346(f3481).

Treatment Response and Mortality among Patients Starting Antiretroviral Therapy with and without Kaposi Sarcoma: A Cohort Study

Maskew M, Fox MP, van Cutsem G, Chu K, MacPhail P, Boulle A, Egger M, for IeDEA Southern Africa

PLOS ONE. 2013 Jun; 8(6):1-8.

The interplay between CD4 cell count, viral load suppression and duration of ART on mortality

Brennan A, Maskew M, Sanne I, Fox MP

Tropical Medicine and International Health. 2013 May; 18(5):619–631.

Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa

Lukas Fenner, Stewart E. Reid, Matthew P. Fox, Daniela Garone, Maureen Wellington, Hans Prozesky, Marcel Zwahlen, Michael Schomaker, Gilles Wandeler, Nzali Kancheya, Andrew Boulle, Robin Wood, German Henostroza, and Matthias Egger

Tropical Medicine and International Health. 2013 Feb; 18(2):194-198.

Prevalent tuberculosis and mortality among HAART initiators

Daniel Westreich, Matthew P. Fox, Annelies Van Rie and Mhairi Maskew

AIDS 2012. 2012 Jul; 26(6):770-773.

Treatment outcomes after 7 years of public-sector HIV treatment

Matthew P. Fox, Kate Shearer, Mhairi Maskew, William Macleod, Pappie Majubae, Patrick Macphaile and Ian Sanne

AIDS 2012. 2012 Jun; 26:1823-1828.

Effectiveness and safety of 30 mg versus 40 mg stavudine regimens: a cohort study among HIV- infected adults initiating HAART in South Africa

Mhairi Maskew, Daniel Westreich, Matthew P Fox, Thapelo Maotoe and Ian M Sanne

Journal of the International AIDS Society. 2012 Mar; 15(1).

Changing From Stavudine to Tenofovir in First-Line Antiretroviral Therapy in South Africa

Alana Brennan, Kate Shearer, & Matthew Fox

South Africa: HE2RO Policy Brief Number 4, Health Economics and Epidemiology Research Office; 2012 Jan.

Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy

Carole L Wallis, Maria A Papathanasopolous, Matthew Fox, Francesca Conradie, Prudence Ive, Catherine Orrell, Jennifer Zeinecker, Ian Sanne, Robin Wood, James McIntyre, Wendy Stevens, the CIPRA-SA project 1 study team

Antiviral Therapy. 2011 Nov; 17:313-320.

Poorer ART Outcomes with Increasing Age in a Large South Africa Cohort

Mhairi Maskew, Alana T. Brennan, A. Patrick MacPhail, Ian M. Sanne and Matthew P. Fox

JIAPAC. 2011 Sep; 11(1):57-65.

Southern Africa Collaboration Long-term Outcomes of Antiretroviral Treatment in Programmes With and Without Routine Viral Load Monitoring in Southern Africa

Keiser O, Chi B, Gsponer T, Boulle A, Orrell C, Phiri S, Maxwell N, Maskew M, Prozesky H, Fox MP, Westfall A, Egger M for the IeDEA

AIDS. 2011 Sep; 25(14):1761-1769.